Metabolomics changes after exercise intervention reveal potential peripheral biomarkers in repeated methamphetamine...

Area of Science:

• Neuroscience
• Metabolomics
• Pharmacology

Background:

• Methamphetamine (MA) use disorder is a significant global health issue.
• The precise peripheral mechanisms through which exercise aids MA addiction treatment remain unclear.
• Identifying reliable biomarkers for exercise interventions in MA addiction is crucial.

Purpose of the Study:

• To identify plasma metabolic biomarkers associated with exercise interventions in a mouse model of MA use disorder.
• To investigate the effects of exercise on reward, anxiety-like, and cognitive behaviors in MA-administered mice.
• To explore the metabolic pathways influenced by exercise in the context of MA addiction.

Main Methods:

• Utilized ultra-high-performance liquid chromatography and tandem mass spectrometry for plasma metabolomics analysis in C57BL/6 J mice.
• Grouped mice into saline control, MA model control, and MA model exercise intervention groups.
• Assessed drug reward using a conditioned place preference paradigm and evaluated behaviors via open field and Y-maze tests.

Main Results:

• Identified 35 differential metabolites distinguishing MA-exposed mice from controls, primarily in membrane lipid, energy, and amino acid metabolism.
• Observed reversal of five reward-related metabolites (L-tryptophan, niacinamide, uridine, 2'-deoxyuridine, uric acid) in the exercise intervention group compared to the MA control group.
• Found that increased uric acid and L-tryptophan levels were linked to improved anxiety-like behavior and cognitive function following exercise.

Conclusions:

• Specific plasma metabolites, including uric acid and L-tryptophan, show potential as biomarkers for the efficacy of exercise interventions in treating MA use disorder.
• These findings suggest that exercise modulates amino acid, energy, purine, and pyrimidine metabolism in MA addiction.
• Further research is warranted to validate these metabolic biomarkers and elucidate their role in exercise-based MA addiction therapy.